Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease

[1]  H. Xiong,et al.  Promoting TFEB nuclear localization with curcumin analog C1 attenuates sensory hair cell injury and delays age-related hearing loss in C57BL/6 mice. , 2023, Neurotoxicology.

[2]  Chanjuan Chai,et al.  Chronic intermittent hypoxia-induced BNIP3 expression mitigates contractile dysfunction and myocardial injury in animal and cell model via modulating autophagy , 2023, Human Cell.

[3]  Zijun Qian,et al.  Autophagy Balances Neuroinflammation in Alzheimer’s Disease , 2022, Cellular and Molecular Neurobiology.

[4]  D. Ganbat,et al.  MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer’s Disease , 2022, Molecular Psychiatry.

[5]  R. V. Prasad,et al.  Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease , 2022, Cell Death & Differentiation.

[6]  J. Weuve,et al.  Aduhelm, the newly approved medication for Alzheimer's disease: what epidemiologists can learn and what epidemiology can offer. , 2022, American journal of epidemiology.

[7]  B. de Strooper,et al.  The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics , 2022, Nature Reviews Drug Discovery.

[8]  T. Farkhondeh,et al.  The interplay between oxidative stress and autophagy: focus on the development of neurological diseases , 2022, Behavioral and Brain Functions.

[9]  X. Deng,et al.  Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer’s disease , 2021, CNS neuroscience & therapeutics.

[10]  Z. Yue,et al.  Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles , 2021, Acta pharmaceutica Sinica. B.

[11]  Ruoli Chen,et al.  Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain , 2021, Alzheimer's research & therapy.

[12]  F. J. Livesey,et al.  Endolysosome and autophagy dysfunction in Alzheimer disease , 2021, Autophagy.

[13]  D. Metzger,et al.  Intermittent Hypoxia Training Prevents Deficient Learning-Memory Behavior in Mice Modeling Alzheimer's Disease: A Pilot Study , 2021, Frontiers in Aging Neuroscience.

[14]  I. Fyfe.  Dense-core plaques could be beneficial in AD , 2021, Nature Reviews Neurology.

[15]  Xifei Yang,et al.  Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB) , 2021, Autophagy.

[16]  Jie Cao,et al.  Intermittent hypoxia-induced autophagy via AMPK/mTOR signaling pathway attenuates endothelial apoptosis and dysfunction in vitro , 2021, Sleep and Breathing.

[17]  G. Petsko,et al.  25‐Hydroxycholesterol amplifies microglial IL‐1beta production in an APOE isoform‐dependent manner , 2020, Alzheimer's & Dementia.

[18]  Y. Surh,et al.  GSK-3β inhibition by curcumin mitigates amyloidogenesis via TFEB activation and anti-oxidative activity in human neuroblastoma cells , 2020, Free radical research.

[19]  A. Alaimo,et al.  Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer’s disease patients , 2020, GeroScience.

[20]  A. Sunkaria,et al.  Sulforaphane Attenuates Aβ Oligomers Mediated Decrease in Phagocytic Activity of Microglial Cells , 2020, Neuroscience.

[21]  G. Petsko,et al.  25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner , 2020, Journal of Neuroinflammation.

[22]  B. Wang,et al.  Intermittent hypoxia improves cognition and reduces anxiety‐related behavior in APP/PS1 mice , 2019, Brain and behavior.

[23]  K. Cheung,et al.  A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models , 2019, Aging cell.

[24]  Jun Zhou,et al.  NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation , 2019, Oxidative medicine and cellular longevity.

[25]  A. Ballabio,et al.  TFEB controls retromer expression in response to nutrient availability , 2019, The Journal of cell biology.

[26]  Wen-Sen Lee,et al.  Intermittent Hypoxia Induces Autophagy to Protect Cardiomyocytes From Endoplasmic Reticulum Stress and Apoptosis , 2019, Front. Physiol..

[27]  D. Green,et al.  LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease , 2019, Cell.

[28]  Wen-Sen Lee,et al.  Intermittent Hypoxia Prevents Myocardial Mitochondrial Ca2+ Overload and Cell Death during Ischemia/Reperfusion: The Role of Reactive Oxygen Species , 2019, Cells.

[29]  F. Kametani,et al.  TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons , 2019, Neuroscience.

[30]  Shuling Song,et al.  Intermittent-Hypoxia-Induced Autophagy Activation Through the ER-Stress-Related PERK/eIF2α/ATF4 Pathway is a Protective Response to Pancreatic β-Cell Apoptosis , 2018, Cellular Physiology and Biochemistry.

[31]  P. Guest,et al.  The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior. , 2018, Methods in molecular biology.

[32]  G. Szabo,et al.  TFEB, a master regulator of lysosome biogenesis and autophagy, is a new player in alcoholic liver disease. , 2018, Digestive medicine research.

[33]  Keith A. Johnson,et al.  Association of anxiety with subcortical amyloidosis in cognitively normal older adults , 2018, Molecular Psychiatry.

[34]  A. Ballabio,et al.  The complex relationship between TFEB transcription factor phosphorylation and subcellular localization , 2018, The EMBO journal.

[35]  J. Hanson,et al.  Microglia in Alzheimer’s disease , 2018, The Journal of cell biology.

[36]  J. Götz,et al.  Tau-based therapies in neurodegeneration: opportunities and challenges , 2017, Nature Reviews Drug Discovery.

[37]  Niu Xiaoyuan,et al.  Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice , 2017, BioMed research international.

[38]  Y. Ke,et al.  Bi-directionally protective communication between neurons and astrocytes under ischemia , 2017, Redox biology.

[39]  D. Metzger,et al.  Intermittent hypoxia training blunts cerebrocortical presenilin 1 overexpression and amyloid-β accumulation in ethanol-withdrawn rats. , 2017, American journal of physiology. Regulatory, integrative and comparative physiology.

[40]  H. Stettner,et al.  Intermittent hypoxic–hyperoxic training on cognitive performance in geriatric patients , 2017, Alzheimer's & dementia.

[41]  Asher Mullard.  Alzheimer amyloid hypothesis lives on , 2016, Nature Reviews Drug Discovery.

[42]  Lei Xi,et al.  Intermittent hypoxia training as non-pharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment , 2016, Experimental biology and medicine.

[43]  K. Rhodes,et al.  The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.

[44]  Chen Zhang,et al.  Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia , 2016, Protein & Cell.

[45]  A. Ballabio,et al.  A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition , 2016, Autophagy.

[46]  Zhixue Liu,et al.  The C-ETS2-TFEB Axis Promotes Neuron Survival under Oxidative Stress by Regulating Lysosome Activity , 2016, Oxidative medicine and cellular longevity.

[47]  A. Alaimo,et al.  Glial alterations from early to late stages in a model of Alzheimer's disease: Evidence of autophagy involvement in Aβ internalization , 2016, Hippocampus.

[48]  Jian-jun Zhao,et al.  TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway. , 2015, DNA and cell biology.

[49]  A. Ballabio,et al.  Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis , 2015, The Journal of Neuroscience.

[50]  G. Mitchell,et al.  Therapeutic potential of intermittent hypoxia: a matter of dose. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[51]  Qingli Xiao,et al.  Enhancing Astrocytic Lysosome Biogenesis Facilitates Aβ Clearance and Attenuates Amyloid Plaque Pathogenesis , 2014, The Journal of Neuroscience.

[52]  Lin Xie,et al.  Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[53]  Nathan D. Kingery,et al.  Scara1 deficiency impairs clearance of soluble Amyloid-β by mononuclear phagocytes and accelerates Alzheimer’s-like disease progression , 2013, Nature Communications.

[54]  F. Heppner,et al.  Microglia as Dynamic and Essential Components of the Amyloid Hypothesis , 2013, Neuron.

[55]  B. Isermann,et al.  Effects of Intermittent Hypoxia on Cognitive Performance and Quality of Life in Elderly Adults: A Pilot Study , 2013, Gerontology.

[56]  Lei Chen,et al.  Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion , 2013, Neurochemistry International.

[57]  C. Bauvy,et al.  Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion , 2013, Cell Research.

[58]  L. Chew,et al.  The Toxicity of Amyloid β Oligomers , 2012, International journal of molecular sciences.

[59]  A. Ballabio,et al.  Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. , 2011, Human molecular genetics.

[60]  Jing Zhang,et al.  Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease , 2011, Molecular Neurodegeneration.

[61]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[62]  A. Walf,et al.  The use of the elevated plus maze as an assay of anxiety-related behavior in rodents , 2007, Nature Protocols.

[63]  J. Ivy,et al.  Effect of Prolonged Intermittent Hypoxia and Exercise Training on Glucose Tolerance and Muscle GLUT4 Protein Expression in Rats , 2004, Journal of Biomedical Science.

[64]  A. Bradford,et al.  Chronic intermittent hypoxia increases haematocrit and causes right ventricular hypertrophy in the rat. , 1999, Respiration physiology.

[65]  A. Ramamoorthy,et al.  Preparation of Stable Amyloid-β Oligomers Without Perturbative Methods. , 2018, Methods in molecular biology.

[66]  M. Masserini,et al.  THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS , 2016 .

[67]  S. Caldwell,et al.  Transcription Factor EB : A Central Regulator of Both the Autophagosome and Lysosome , 2012 .